ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Epidemiologic methods"

  • Abstract Number: 1124 • 2018 ACR/ARHP Annual Meeting

    Epidemiological Characteristics of Inpatient Admissions for Acute Inflammatory Gout Arthropathy and Factors Affecting Length of Stay: A National Level Study

    Vagishwari Murugesan and Jennifer Tran, Internal Medicine, Medstar Washington Hospital Center, Washington, DC

    Background/Purpose:Gout is a common cause of inflammatory arthritis due to accumulation of monosodium urate crystals in joints, bones and soft tissues. The aim of the…
  • Abstract Number: 2220 • 2018 ACR/ARHP Annual Meeting

    Gout, Flares and Allopurinol Use: A Population Based Study

    Charlotte Proudman1, Susan Lester2,3, David Gonzalez-Chica4, Tiffany Gill3, Nicola Dalbeth5 and Catherine Hill6,7, 1Medical School, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, Australia, 2Rheumatology Unit, The Queen Elizabeth Hospital, Adelaide, Australia, 3Discipline of Medicine, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, Australia, 4Discipline of General Practice, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, Australia, 5Department of Medicine, Faculty of Medical and Health Sciences., University of Auckland, Auckland, New Zealand, 6The Queen Elizabeth Hospital, Adelaide, Australia, 7Medicine, The University of Adelaide, Adelaide, Australia

    Background/Purpose: Gout flares may often be self-managed, but there is a paucity of population-based data. The aim of this study was to determine the prevalence…
  • Abstract Number: 1130 • 2018 ACR/ARHP Annual Meeting

    Chronic Risk Factors for Recurrent Gout Flares Among Established Gout Patients: A Prospective Cohort Analysis

    Yuqing Zhang1, Jie Wei2, Chio Yokose2, Sharan K. Rai3,4 and Hyon K. Choi2, 1Department of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, MA, 2Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, MA, 3Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, MA, 4Graduate School of Arts and Sciences, Harvard University, Cambridge, MA

    Background/Purpose: Understanding the risk factors for recurrent flares among established gout patients is directly relevant to clinical care; however, relevant data are scarce. A previous…
  • Abstract Number: 2232 • 2018 ACR/ARHP Annual Meeting

    Prevalence of Gout in the Surviving U.S. Solid Organ Transplant Population

    Mark D. Brigham1, Thilan Tudor1, Gavin Miyasato1, Jeffrey D. Kent2, Brian LaMoreaux3 and Brian F. Mandell4, 1Trinity Partners, Waltham, MA, 2Medical Affairs, Horizon Pharma USA, Inc, Lake Forest, IL, 3Horizon Pharma USA, Inc, Lake Forest, IL, 4Rheumatology, Cleveland Clinic, Cleveland, OH

    Background/Purpose: Although incidence and survival are frequent topics within the solid organ transplant (SOT) literature, there are no recent publications on the total size of…
  • Abstract Number: 1131 • 2018 ACR/ARHP Annual Meeting

    The Prevalence and Incidence of Gout, Its Associated Comorbidities and Treatment Pattern: An Epidemiological Study from Germany

    Uta Kiltz1, Fernando Perez-Ruiz2, Till Uhlig3, Tim L. Jansen4, Ravichandra Karra Gurunath5, Niklas Schmedt6, Wolfgang Galetzka6, Gudula Petersen5, Tonio Schoenfelder7 and Anne-Kathrin Tausche8, 1Rheumazentrum Ruhrgebiet, Herne, and Ruhr-University, Bochum, Herne, Germany, 2BioCruces Health Research Institute, Barakaldo, Spain, 3University of Oslo, Oslo, Norway, 4Rheumatology, VieCuri Medical Centre, Venlo, Netherlands, 5Grünenthal GmbH, Aachen, Germany, 6InGef – Institute for Applied Health Research, Berlin, Germany, 7Institute for Applied Health Services Research, Berlin, Germany, 8Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Dresden, Germany

    Background/Purpose: The most common type of inflammatory arthritis in Germany is gout, however the last epidemiological study was done a decade ago (Annemanns, 2007). This…
  • Abstract Number: 2261 • 2018 ACR/ARHP Annual Meeting

    Long-Term Outcome of Pulmonary Sarcoidosis: A Population-Based Cohort Study from 1976-2013

    Patompong Ungprasert1,2, Cynthia S. Crowson3, Eva M. Carmona Porquera4 and Eric L. Matteson5, 1Clinical Epidemiology Unit, Department of Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, 2Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN, 3Health Sciences Research, Mayo Clinic College of Medicine and Science, Rochester, MN, 4Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN, 5Division of Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN

    Long-term Outcome of Pulmonary Sarcoidosis: A Population-Based Cohort Study from 1976-2013  Background/Purpose: A hallmark of sarcoidosis is lung disease, which has variable expression. This study…
  • Abstract Number: 1135 • 2018 ACR/ARHP Annual Meeting

    Genome-Wide Meta-Analysis Identified Two Novel Variants Associated with Hallux Valgus

    Liubov Arbeeva1, Braxton Mitchell2, Rebecca D. Jackson3, Michelle S. Yau4, Kathleen Ryan5, Yvonne M. Golightly6, Marian T. Hannan7, Amanda Nelson8, Joanne M. Jordan9 and Marc C. Hochberg2, 1TARC, University of North Carolina at Chapel Hill, Chapel Hill, NC, 2School of Medicine, University of Maryland, Baltimore, MD, 3Ohio State University, Columbus, OH, 4Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School, Boston, MA, 5University of Maryland, Baltimore, MD, 6Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, 7Institute for Aging Research, Hebrew SeniorLife & Harvard Medical School, Boston, MA, 8UNC School of Medicine, Chapel Hill, NC, 9Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC

    Background/Purpose: Hallux valgus (HV) is a common foot disorder that is highly heritable. A genome-wide association study (GWAS) conducted in 4,409 Caucasians from the Framingham…
  • Abstract Number: 2262 • 2018 ACR/ARHP Annual Meeting

    Increased Risk of Sarcoidosis Among Patients with Celiac Disease: A Systematic Review and Meta-Analysis

    Patompong Ungprasert1, Karn Wijarnpreecha2, Panadeekarn Panjawatanan3, Ploypin Lertjitbanjong2 and Juan Corral4, 1Clinical Epidemiology Unit, Department of Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, 2Internal medicine, Bassett medical center, cooperstown, NY, 3Medicine, Chiang Mai University, Chiang Mai, Thailand, 4Internal medicine, Mayo Clinic, Jacksonville, Jacksonville, FL

    Increased Risk of Sarcoidosis among Patients with Celiac Disease: A Systematic Review and Meta-Analysis AbstractBackground/Purpose: Several epidemiologic studies have suggested that patients with celiac disease may…
  • Abstract Number: 1137 • 2018 ACR/ARHP Annual Meeting

    Prediction Models for Poor Function Outcomes over 10 Years in Persons at High Risk for Knee Osteoarthritis

    Leena Sharma1, Orit Almagor1, Alison H. Chang1, C. Kent Kwoh2, Michael C. Nevitt3, Marc C. Hochberg4, Rebecca D. Jackson5, Charles B. Eaton6, Jane A. Cauley7, Julie Szymaszek8 and Joan S. Chmiel1, 1Northwestern University, Chicago, IL, 2University of Arizona, Tucson, AZ, 3UCSF, San Francisco, CA, 4University of Maryland School of Medicine, Baltimore, MD, 5Ohio State University, Columbus, OH, 6Family Medicine, Memorial Hospital of Rhode Island, Pawtucket, RI, 7University of Pittsburgh, PIttsburgh, PA, 8Northwestern University Feinberg School of Medicine, Chicago, IL

    Background/Purpose:   Among persons at high risk for knee osteoarthritis (OA), identifying those who will have function decline is important; instituting prevention strategies in all…
  • Abstract Number: 2305 • 2018 ACR/ARHP Annual Meeting

    Peripheral Arterial Disease Is Associated with an Increased Risk of Subsequent Hip Fracture: A Systematic Review and Meta-Analysis of Cohort Studies

    Patompong Ungprasert1, Karn Wijarnpreecha2, Charat Thongprayoon2 and Wisit Cheungpasitporn3, 1Clinical Epidemiology Unit, Department of Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, 2Internal medicine, Bassett medical center, cooperstown, NY, 3Medicine, University of Mississippi Medical center, Jackson, MS

    Peripheral Arterial Disease is Associated with an Increased Risk of Subsequent Hip Fracture: A Systematic Review and Meta-Analysis of Cohort Studies             AbstractBackground/Purpose: Studies have suggested…
  • Abstract Number: 1140 • 2018 ACR/ARHP Annual Meeting

    Cause-Specific Mortality in Knee, Hip and Hand Osteoarthritis

    Aleksandra Turkiewicz, Aliasghar Kiadaliri and Martin Englund, Clinical Sciences Lund, Clinical Epidemiology Unit, Lund University, Lund, Sweden

    Background/Purpose: All-cause mortality in osteoarthritis (OA) is reported to be increased. However, the knowledge about cause-specific mortality in OA is still very limited. Thus, our…
  • Abstract Number: 2487 • 2018 ACR/ARHP Annual Meeting

    Comparison of QOL Evaluation Using EQ-5D-3L and EQ-5D-5L in Japanese RA Patients: A Study Using the IORRA Cohort

    Kumiko Saka1, Eiichi Tanaka2, Eisuke Inoue1,3, Mai Abe1, Mika kawano1, Naohiro Sugitani1,4, Eri Sugano1, Moeko Ochiai1, Rei Yamaguchi1, Yoko Shimizu1, Naoki Sugimoto1, Katsunori Ikari1, Ayako Nakajima1,5, Atsuo Taniguchi1 and Hisashi Yamanaka6, 1Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, 2Institute of Rheumatology, Tokyo Women's Medical University, Toko, Japan, 3Division of Medical Informatics, St. Marianna University School of Medicine, Kawasaki, Japan, 4Center for Rheumatic Diseases, Mie University Hospital, Tsu city, Japan, 5Center for Rheumatic Diseases, Mie University Hospital, Tsu, Japan, 6Institute of Rheumatology, Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan

    Background/Purpose: EQ-5D-3L is frequently used for evaluation of quality of life (QOL). However, there are several problems when using EQ-5L-3L. Evaluation using EQ-5L-3L might not…
  • Abstract Number: 145 • 2017 ACR/ARHP Annual Meeting

    Cause-Specific Mortality in a Large Population-Based Cohort of Rheumatoid Arthritis Patients in Italy

    Francesca Ometto1, UGO FEDELI2, ELENA SCHIEVANO2, Costantino Botsios3, MARIA CHIARA CORTI2 and Leonardo Punzi4, 1Rheumatology Unit, Department of Medicine - DIMED, University of Padova, PADOVA, Italy, 2Epidemiological Department, Veneto Region, VENETO, Italy, 3Rheumatology Unit, Department of Medicine - DIMED, University of Padova, Padova, Italy, 4Rheumatology Unit, Department of Medicine DIMED, University of Padova, Padova, Italy

    Background/Purpose: Studies on mortality in RA from Italy are completely lacking. The aim of our study was to investigate cause-specific mortality in RA subjects living…
  • Abstract Number: 995 • 2017 ACR/ARHP Annual Meeting

    The Epidemiology of Psoriatic Arthritis in Israel – a Population-Based Study

    Lihi Eder1,2, Arnon Dov Cohen3, Ilan Feldhamer4, Sari Greenberg-Dotan4, Eraz Batat4 and Devy Zisman5, 1Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada, 2Medicine, University of Toronto, Toronto, ON, Canada, 33Chief Physician’s Office, Central Headquarters, Clalit Health Services, Tel Aviv, Israel, 4Chief Physician’s Office, Central Headquarters, Clalit Health Services, Tel Aviv, Israel, 5The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel

    Background/Purpose: There is limited information on the epidemiology of Psoriatic Arthritis (PsA) in general and in Middle Eastern populations in particular. The aims of this…
  • Abstract Number: 2893 • 2017 ACR/ARHP Annual Meeting

    The Use of Natural Language Processing to Identify, Retrieve, Report, and Correct Observational Data on US Veterans Enrolled in the Veterans Affairs Rheumatoid Arthritis Registry

    Grant Cannon1, Jorge Rojas1, Neill Bell2, Andreas Reimold3, Ted R. Mikuls4, Namrata Singh5, Gail S. Kerr6, Pascale Schwab7, Jennifer Barton7, Liron Caplan8, Joshua Baker9, Angelo L. Gaffo10, J. Steuart Richards11, Deana Lazaro12, Vikas Majithia13 and Brian Sauer1, 1Salt Lake City VA Medical Center and University of Utah, Salt Lake City, UT, 2Salt Lake City VA Medical Center and University of Utah, Dallas VA Medical Center, Dallas, TX, 3Dallas VA Medical Center and University of Texas Southwestern, Dallas, TX, 4VA Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, NE, 5VA Nebraska-Western Iowa Health Care System and University of Iowa, Omaha, IA, 6Washington DC VA Medical Center, Georgetown and Howard University Hospitals, Washington, DC, 7Portland VA Medical Center and University of Oregon, Portland, OR, 8Denver VA Medical Center and Univerity of Colorado, Denver, CO, 9Philadelphia VA Medical Center and University of Pennsylvania, Philadelphia, PR, 10Birmingham VA Medical Center and University of Alabama at Birmingham, Birmingham, AL, 11Pittsburgh VA Medical Center and University Of Pittsburgh, Pittsburgh, PA, 12Brooklyn VA Medical Center and SUNY Downstate, Brooklyn, NY, 13Jackson VA Medical Center and University of Mississippi, Jackson, MS

    Background/Purpose:   The Veterans Affairs (VA) Rheumatoid Arthritis (RA) (VARA) registry is an observational cohort study at 12 VA medical centers that prospectively collects clinical…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 17
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology